ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Secret Budget Sessions Ended; HEW Out To Lim. Future NCI Funds

April 2, 1976

In Brief: Harvard’s Richmond Said To Be The Choice As Asst. secretary; Lee Clark Convalescing

May 6, 1977

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

Funding Opportunities.

May 24, 2002

In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill

February 14, 1986

FDA News< Regulations To Ease For Advertising Drugs On TV, Radio

September 12, 1997